Artigos de Perspetiva
Heart Failure: A World in Constant Evolution
Conteúdo principal do artigo
Doroteia Reis Silva
Detalhes do artigo
Este trabalho encontra-se publicado com a Creative Commons Atribuição-NãoComercial 4.0.
Referências
Ceia F, Fonseca C, Mota T, Morais H, Matias F, de Sousa A, et al. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur J Heart Fail. 2002; 4: 531–39. doi: 10.1016/s1388-9842(02)00034-x.
Braunwald E. Heart failure. JACC Heart Fail. 2013;1:1-20. doi: 10.1016/j.jchf.2012.10.002. .
Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, et al. Heart failure: preventing disease and death worldwide. ESC Heart Fail. 2014;1:4-25. doi: 10.1002/ehf2.12005.
Baptista R, Silva Cardoso J, Canhão H, Maria Rodrigues A, Kislaya I, Franco F, et al. Portuguese Heart Failure Prevalence Observational Study (PORTHOS) rationale and design - A population-based study. Rev Port Cardiol. 2023;42:985-95. doi: 10.1016/j.repc.2023.10.004.
Fonseca C, Brás D, Araújo I, Ceia F. Insuficiência cardíaca em números: estimativas para o século XXI em Portugal. Rev Port Cardiol. 2018; 37: 97-104.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2022;400:1938-52. doi: 10.1016/S0140-6736(22)02076-1.
Mebazaa A, Davison B, Chioncel O, Cohen-Solal A, Diaz R, Filippatos G, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet. 2022;400:1938-52. doi: 10.1016/S0140-6736(22)02076-1.
Oraii A, McIntyre WF, Parkash R, Kowalik K, Razeghi G, Benz AP, et al. Atrial fibrillation ablation in heart failure with reduced vs preserved ejection fraction: a systematic review and meta-analysis. JAMA Cardiol. 2024;9:545-55. doi: 10.1001/jamacardio.2024.0675.
Schmitto JD, Shaw S, Garbade J, Gustafsson F, Morshuis M, Zimpfer D, et al. Fully magnetically centrifugal left ventricular assist device and long-term outcomes: the ELEVATE registry. Eur Heart J. 2024;45:613-25. doi: 10.1093/eurheartj/ehad658. .
Schroder JN, Patel CB, DeVore AD, Bryner BS, Casalinova S, Shah A, et al. Transplantation Outcomes with Donor Hearts after Circulatory Death. N Engl J Med. 2023;388:2121-31. doi: 10.1056/NEJMoa2212438.
